IRIS
CIANI, ORIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.117
NA - Nord America 3.791
AS - Asia 1.017
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 18
SA - Sud America 18
AF - Africa 9
Totale 9.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.567
IT - Italia 2.220
IE - Irlanda 1.098
GB - Regno Unito 445
CN - Cina 439
UA - Ucraina 417
DE - Germania 227
CA - Canada 222
SE - Svezia 222
FI - Finlandia 176
HK - Hong Kong 148
VN - Vietnam 144
TR - Turchia 75
FR - Francia 68
BG - Bulgaria 53
IN - India 52
KZ - Kazakistan 47
KR - Corea 46
BE - Belgio 31
CZ - Repubblica Ceca 26
ES - Italia 20
RO - Romania 20
IR - Iran 18
NL - Olanda 18
EU - Europa 17
AU - Australia 16
CH - Svizzera 11
DK - Danimarca 10
BR - Brasile 9
JP - Giappone 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
PT - Portogallo 7
PL - Polonia 6
NO - Norvegia 5
LT - Lituania 4
LU - Lussemburgo 4
LV - Lettonia 4
PH - Filippine 4
RU - Federazione Russa 4
SG - Singapore 4
CL - Cile 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
PE - Perù 3
TH - Thailandia 3
AL - Albania 2
CO - Colombia 2
GE - Georgia 2
ID - Indonesia 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NZ - Nuova Zelanda 2
OM - Oman 2
PK - Pakistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 9.989
Salva come PNG Salva come JPEG
Città #
Dublin 1.094
Chandler 673
Milan 488
Jacksonville 334
Ann Arbor 258
Southend 215
Toronto 186
Rome 157
Redmond 149
Hong Kong 147
Dearborn 146
New York 144
Beijing 137
Dong Ket 130
Helsinki 117
Wilmington 116
Houston 111
Lawrence 97
Modena 91
Boston 90
Ashburn 85
Izmir 68
Redwood City 50
Mountain View 48
Almaty 47
Palombara Sabina 47
Seoul 42
Boardman 41
Seattle 41
Woodbridge 40
Fairfield 36
Naples 36
Bologna 30
Los Angeles 30
Frankfurt am Main 28
Brussels 27
Fremont 27
Turin 24
Ottawa 22
Bari 19
Catania 19
Washington 18
Bucharest 16
Hefei 16
Kunming 15
Nanjing 15
West Jordan 15
Florence 14
Chennai 13
Jinan 13
Robbiate 12
Lappeenranta 11
Napoli 11
Trento 11
Bonndorf 10
Dallas 10
Falls Church 10
Norwalk 10
Palermo 10
Shenyang 10
Torino 10
Darwin 9
Guangzhou 9
Monza 9
Nardò 9
Trieste 9
Bergamo 8
Padova 8
Ardabil 7
Auburn Hills 7
Carrara 7
Genoa 7
Livorno 7
London 7
Messina 7
Monmouth Junction 7
Perugia 7
Cento 6
Crotone 6
Desenzano Del Garda 6
Forlì 6
Nanchang 6
Novara 6
Pavia 6
Pomezia 6
Reggio Emilia 6
Taranto 6
Trapani 6
Udine 6
Verona 6
Zhengzhou 6
Amsterdam 5
Bacoli 5
Brindisi 5
Catanzaro 5
Chengdu 5
Ciampino 5
Corigliano Calabro 5
Dubai 5
Duncan 5
Totale 6.190
Salva come PNG Salva come JPEG
Nome #
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 293
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 274
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 245
Esiti di salute e performance del Servizio Sanitario Nazionale 236
I dispositivi medici in Italia: un settore, tanti mercati 204
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 194
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 186
Gli esiti di salute del Servizio Sanitario Nazionale 162
EQ-5D-5L population norms for Italy 148
Current and Future Trends in the HTA of Medical Devices 148
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 148
Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis 147
Gli esiti di salute del Servizio Sanitario Nazionale 139
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 138
Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis 137
La dimensione del settore dei dispositivi medici 134
Endpoint surrogati e politiche sanitarie: l’importanza di metodi di validazione adeguati 134
The Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer 126
Surrogate endpoints in health technology assessment: an international review of methodological guidelines 121
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 114
Integrating HTA principles into procurement of medical devices: the Italian national HTA programme for medical devices 113
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 112
Patient-reported outcome measures in core outcome sets targeted overlapping domains but through different instruments 109
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration 106
Valutare l’impatto dell’HTA come strumento di governo dell’innovazione tecnologica: modelli teorici e studi empirici 105
I processi di valutazione dei dispositivi medici e delle tecnologie sanitarie 104
Comparing drug and non-drug technologies in comparative effectiveness research 103
Mud-bath therapy in addition to usual care in bilateral knee osteoarthritis: economic evaluation alongside a randomized controlled trial 102
Core outcome set in surgical oncology: why, what and how to measure 102
An economic perspective on urinary tract infection: the "costs of resignation" 100
A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement 100
Cost–effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma 98
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 98
Measuring value in health care: a comparative analysis of value-based frameworks 96
European diabetes research and its funding, 2002–2013 95
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 94
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 93
A scoping review of core outcome sets and their 'mapping' onto real-world data using prostate cancer as a case study 93
Exercise training for chronic heart failure (ExTraMATCH II): why all data are not equal 92
Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study 92
Distinguishing features in the assessment of mHealth apps 92
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 92
The rise of rules: will the new regulation of medical devices make us safer? 91
Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer 90
Determinants of demand for total hip and and knee arthroplasty: a systematic literature review 87
Hospital-based HTA: quale valore per la valutazione delle tecnologie nelle Aziende Sanitarie italiane? 87
Time to review the role of surrogate end points in health policy: state of the art and the way forward 87
Complete cytogenetic response and major molecular response as surrogate outcomes for overall survival in first-line treatment of chronic myelogenous leukemia: a case study for technology appraisal on the basis of surrogate outcomes evidence 86
Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms 85
Introduction to economic evaluation and health technology assessment 84
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study 82
The impacts of diabetes research from 31 European Countries in 2002 to 2013 82
The evaluation of medical devices: are we getting closer to solve the puzzle? A review of recent trends 81
Harnessing digital health technologies during and after the COVID-19 pandemic: context matters 81
Broadening the concept of value: a scoping review on the option value of medical technologies 81
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework 80
Health technology assessment methods guidelines for medical devices: how can we address the gaps? the international federation of medical and biological engineering perspective 79
Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials 79
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy. 78
La gestione dell'innovazione tecnologica in sanità: analisi e confronto di alcune politiche regionali in Italia 77
Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials 77
An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study 77
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study 76
Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany 76
Urinary Tract Infections – An Economic Issue 75
Response to COVID-19: was Italy (un)prepared? 75
Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer 74
Coverage with evidence development for medical devices in Europe: can practice meet theory? 74
Quantitative body movement and gesture assessment in ergonomics. 73
A more evidence based approach to the use of surrogate end points in policy making 73
Validation of surrogate end points for overall survival in advanced colorectal cancer: a harmonized approach is needed 72
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis 72
Value-based healthcare: il nuovo approccio di AIFA alla determinazione multidimensionale del valore 72
Esiti di salute e performance del Servizio Sanitario Nazionale 72
Surrogate, friend or foe? The need for case studies of the use of surrogate outcomes in cost-effectiveness analyses 71
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal 71
Health technology assessment of medical devices: a survey of non-European union agencies 70
Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps 69
Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis 68
Assessment of nonfatal myocardial infarction as a surrogate for all-cause and cardiovascular mortality in treatment or prevention of coronary artery disease: a meta-analysis of randomized clinical trials 68
Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers 66
Linking the regulatory and reimbursement processes for medical devices: the need for integrated assessments 66
Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials 66
Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges 66
Corona-regionalism? Differences in regional responses to COVID-19 in Italy 66
The role of health technology assessment bodies in shaping drug development 63
Value lies in the eye of the patients: the why, what, and how of patient-reported outcomes measures 63
Pervasive technology in Neonatal Intensive Care Unit: a prototype for newborns unobtrusive monitoring 61
A call for better reporting of trials using surrogate primary endpoints 50
Esiti di salute e performance del Servizio Sanitario Nazionale 49
Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis 48
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective 47
Validity of surrogate endpoints and their impact on coverage recommendations: a retrospective analysis across international Health Technology Assessment agencies 45
The importance of using the appropriate model for systematic reviews and meta-analyses-reply 45
Valorizzare gli esiti riferiti dal paziente : opportunità e sfide 44
Commentary: Nothing but a toothbrush for beginning the reduction of the postoperative costs in thoracic surgery 41
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges 41
Lung cancer stage distribution from before COVID-19 through 18 months of the pandemic: the experience of a large-volume oncological referral centre 41
Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence 41
Editorial: Near-infrared fluorescence guided surgery: state of the evidence from a health technology assessment perspective 37
Totale 9.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.989
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019120 0 0 0 0 0 0 0 0 0 0 28 92
2019/20201.518 45 24 84 64 124 246 245 134 153 220 39 140
2020/20211.350 59 86 33 106 143 91 129 58 156 118 116 255
2021/20221.500 107 220 50 68 140 66 58 233 72 145 143 198
2022/20233.178 202 173 86 266 203 223 83 162 1.398 121 161 100
2023/20241.806 109 142 149 59 258 287 193 324 98 180 7 0
Totale 10.363